Ganciclovir Side Effects: What to Expect and When to Call Your Doctor

Ganciclovir is a powerful antiviral medication that carries serious risks — including a boxed warning (the FDA's most serious warning level) about blood count problems, fertility effects, and cancer risk based on animal data. Understanding what side effects to expect, which ones are dangerous, and when to seek medical help is essential for anyone taking this medication.

This guide covers side effects for both the IV injection form (Cytovene-IV) and the ophthalmic gel form (Zirgan). The side effect profiles are very different — the IV form has major systemic risks, while the ophthalmic gel has primarily local effects.

Boxed Warnings — The Most Serious Risks

Ganciclovir IV carries four boxed warnings from the FDA:

Hematologic Toxicity: Ganciclovir can severely lower white blood cells (neutropenia/granulocytopenia), red blood cells (anemia), and platelets (thrombocytopenia). In clinical trials, neutropenia (very low white cell count) occurred in more than 1 in 5 patients. These blood count problems can be life-threatening. Regular blood tests are required during treatment.

Impairment of Fertility: Based on animal data and limited human data, ganciclovir may cause temporary or permanent inhibition of sperm production in men and suppression of fertility in women. Men should use barrier contraception during treatment and for at least 90 days after stopping. Women of childbearing age should use effective contraception during treatment and for at least 30 days after stopping.

Fetal Toxicity: Animal studies show ganciclovir causes birth defects and fetal harm. Ganciclovir should not be used during pregnancy unless the benefit clearly outweighs the risk. If you become pregnant while taking ganciclovir, contact your doctor immediately.

Mutagenesis and Carcinogenesis: Animal data suggests ganciclovir has the potential to cause cancer in humans. This risk is weighed against the serious nature of CMV disease in immunocompromised patients. Discuss this risk with your doctor before starting treatment.

Common Side Effects of Ganciclovir IV

The most frequently reported side effects with IV ganciclovir (occurring in 1% or more of patients) include:

Neutropenia (low white blood cell count) — the most common serious side effect

Anemia (low red blood cell count)

Thrombocytopenia (low platelet count)

Fever

Nausea and vomiting

Diarrhea and abdominal pain

Headache

Fatigue and weakness

Elevated serum creatinine (sign of kidney stress)

Sweating, rash

Pain or phlebitis at the injection site (due to the high pH of the solution)

Serious Side Effects — Seek Immediate Help

Some side effects of ganciclovir require immediate medical attention. Call your doctor or go to the emergency room if you experience:

Fever, chills, or signs of infection (may indicate dangerous neutropenia)

Unusual bruising or bleeding (low platelets)

Extreme fatigue or pallor (severe anemia)

Seizures (particularly if co-administered with imipenem-cilastatin)

Decreased urination or swelling (signs of kidney problems)

Confusion, hallucinations, or sudden changes in mental status

Side Effects of Zirgan (Ganciclovir Ophthalmic Gel)

The ophthalmic gel has a much more limited side effect profile, as systemic absorption from the eye is minimal. Common side effects with Zirgan include:

Blurred vision (reported in up to 60% of patients — usually transient)

Eye irritation or burning (reported in ~20%)

Punctate keratitis (small surface corneal defects, ~5%)

Conjunctival redness (hyperemia, ~5%)

Required Monitoring During Treatment

Because ganciclovir IV can cause life-threatening blood count changes, regular lab monitoring is not optional — it is a required part of safe treatment:

Complete blood count (CBC) with differential — at least weekly during induction

Serum creatinine and kidney function — monitored throughout treatment

CMV viral load — to assess treatment response

For information on medications that interact with ganciclovir and worsen these side effects, see our post on ganciclovir drug interactions.